Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Inc ILMN.OQ reported quarterly adjusted earnings of $1.31 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.19. The mean expectation of seventeen analysts for the quarter was for earnings of $1.23 per share. Wall Street expected results to range from $1.20 to $1.26 per share.
Revenue rose 9.4% to $1.16 billion from a year ago; analysts expected $1.13 billion.
Illumina Inc's reported EPS for the quarter was $1.35.
The company reported quarterly net income of $207 million.
Illumina Inc shares had risen by 16.6% this quarter and gained 56.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 7 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Illumina Inc is $170.00, about 20.6% below its last closing price of $205.09
This summary was machine generated from LSEG data July 31 at 06:17 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.23 | 1.31 | Beat |
Mar. 31 2026 | 1.05 | 1.15 | Beat |
Dec. 31 2025 | 1.23 | 1.35 | Beat |
Sep. 30 2025 | 1.17 | 1.34 | Beat |
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research